 Peter Dahlberg
Concepts (222)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lung Transplantation | 12 | 2010 | 338 | 1.850 |
Why?
| | Graft Survival | 5 | 2010 | 526 | 0.750 |
Why?
| | Esophageal Neoplasms | 4 | 2012 | 349 | 0.640 |
Why?
| | Lung Diseases | 6 | 2007 | 787 | 0.620 |
Why?
| | Cause of Death | 3 | 2008 | 472 | 0.430 |
Why?
| | Aprotinin | 2 | 2010 | 11 | 0.390 |
Why?
| | Serine Proteinase Inhibitors | 2 | 2010 | 51 | 0.380 |
Why?
| | Eukaryotic Initiation Factor-4F | 1 | 2012 | 4 | 0.370 |
Why?
| | RNA Caps | 1 | 2012 | 33 | 0.370 |
Why?
| | Reperfusion Injury | 4 | 2007 | 300 | 0.330 |
Why?
| | Survival Analysis | 8 | 2008 | 1385 | 0.320 |
Why?
| | Primary Graft Dysfunction | 1 | 2010 | 35 | 0.310 |
Why?
| | Adenocarcinoma | 3 | 2009 | 931 | 0.300 |
Why?
| | Protein Biosynthesis | 1 | 2012 | 458 | 0.290 |
Why?
| | Genes, erbB-2 | 2 | 2004 | 33 | 0.270 |
Why?
| | Severity of Illness Index | 5 | 2007 | 2925 | 0.270 |
Why?
| | Ventilation-Perfusion Ratio | 1 | 2007 | 12 | 0.260 |
Why?
| | Endotoxins | 3 | 1997 | 221 | 0.260 |
Why?
| | Blood Gas Analysis | 1 | 2007 | 83 | 0.260 |
Why?
| | Organ Preservation | 1 | 2008 | 130 | 0.250 |
Why?
| | Blood Proteins | 4 | 1997 | 249 | 0.250 |
Why?
| | Hernia, Hiatal | 2 | 2006 | 41 | 0.230 |
Why?
| | Coronary Artery Bypass | 2 | 2008 | 269 | 0.230 |
Why?
| | Gene Amplification | 2 | 2009 | 121 | 0.230 |
Why?
| | Graft Rejection | 1 | 2008 | 540 | 0.210 |
Why?
| | Tissue and Organ Procurement | 1 | 2008 | 346 | 0.200 |
Why?
| | Lipopolysaccharides | 7 | 1997 | 863 | 0.200 |
Why?
| | Membrane Proteins | 4 | 1997 | 1167 | 0.190 |
Why?
| | Mitral Valve Insufficiency | 1 | 2003 | 72 | 0.190 |
Why?
| | Postoperative Complications | 6 | 2008 | 2920 | 0.180 |
Why?
| | Blood Bactericidal Activity | 4 | 1997 | 42 | 0.170 |
Why?
| | Pulmonary Fibrosis | 1 | 2005 | 395 | 0.170 |
Why?
| | Fundoplication | 1 | 2001 | 54 | 0.170 |
Why?
| | Tumor Necrosis Factor-alpha | 5 | 1997 | 1217 | 0.170 |
Why?
| | Time Factors | 6 | 2008 | 7183 | 0.170 |
Why?
| | Coronary Disease | 1 | 2003 | 386 | 0.170 |
Why?
| | Heart Valve Prosthesis Implantation | 1 | 2003 | 197 | 0.170 |
Why?
| | Macrophages | 4 | 1996 | 1511 | 0.160 |
Why?
| | Gene Expression | 2 | 2009 | 1490 | 0.160 |
Why?
| | Retrospective Studies | 14 | 2008 | 17101 | 0.150 |
Why?
| | Extracorporeal Membrane Oxygenation | 1 | 2004 | 383 | 0.150 |
Why?
| | Gram-Negative Bacteria | 2 | 1997 | 81 | 0.150 |
Why?
| | Middle Aged | 15 | 2010 | 35928 | 0.140 |
Why?
| | Survival Rate | 4 | 2010 | 2092 | 0.140 |
Why?
| | Peptide Fragments | 3 | 1997 | 699 | 0.140 |
Why?
| | Laparoscopy | 2 | 2006 | 475 | 0.140 |
Why?
| | Lung | 2 | 2007 | 4109 | 0.130 |
Why?
| | Follow-Up Studies | 4 | 2010 | 5417 | 0.120 |
Why?
| | Cell Line, Tumor | 4 | 2012 | 3550 | 0.120 |
Why?
| | Respiratory Function Tests | 3 | 2008 | 547 | 0.120 |
Why?
| | Tissue Donors | 3 | 2010 | 424 | 0.120 |
Why?
| | Treatment Outcome | 7 | 2010 | 11695 | 0.110 |
Why?
| | Stomach Neoplasms | 2 | 2009 | 128 | 0.110 |
Why?
| | Adult | 12 | 2010 | 40506 | 0.110 |
Why?
| | Probability | 2 | 2008 | 312 | 0.110 |
Why?
| | Male | 18 | 2010 | 72406 | 0.110 |
Why?
| | Female | 19 | 2010 | 78376 | 0.110 |
Why?
| | RNA, Neoplasm | 2 | 2004 | 86 | 0.100 |
Why?
| | Humans | 25 | 2012 | 144957 | 0.100 |
Why?
| | Anti-Infective Agents | 1 | 1996 | 242 | 0.100 |
Why?
| | Hypertension, Pulmonary | 1 | 2005 | 1980 | 0.100 |
Why?
| | Recombinant Fusion Proteins | 1 | 1996 | 675 | 0.100 |
Why?
| | Hospital Mortality | 2 | 2008 | 1031 | 0.100 |
Why?
| | Gene Expression Regulation, Neoplastic | 2 | 2012 | 1462 | 0.090 |
Why?
| | RNA, Small Interfering | 2 | 2012 | 635 | 0.090 |
Why?
| | RNA, Messenger | 3 | 2012 | 2832 | 0.090 |
Why?
| | Proteasome Inhibitors | 1 | 2012 | 40 | 0.090 |
Why?
| | Bortezomib | 1 | 2012 | 55 | 0.090 |
Why?
| | Boronic Acids | 1 | 2012 | 37 | 0.090 |
Why?
| | Gene Targeting | 1 | 2012 | 82 | 0.090 |
Why?
| | Immunoglobulin G | 1 | 1996 | 893 | 0.090 |
Why?
| | Apoptosis | 2 | 2012 | 2430 | 0.090 |
Why?
| | Feedback, Physiological | 1 | 2012 | 83 | 0.090 |
Why?
| | Escherichia coli Infections | 3 | 1997 | 129 | 0.090 |
Why?
| | Ubiquitin | 1 | 2012 | 86 | 0.090 |
Why?
| | Risk Assessment | 3 | 2008 | 3676 | 0.090 |
Why?
| | Cohort Studies | 4 | 2007 | 5965 | 0.090 |
Why?
| | Proteolysis | 1 | 2012 | 173 | 0.090 |
Why?
| | Pyrazines | 1 | 2012 | 93 | 0.090 |
Why?
| | Drug Synergism | 1 | 2012 | 357 | 0.090 |
Why?
| | Gene Silencing | 1 | 2012 | 205 | 0.090 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2012 | 159 | 0.080 |
Why?
| | Multivariate Analysis | 2 | 2005 | 1540 | 0.080 |
Why?
| | Enzyme Activation | 1 | 2012 | 768 | 0.080 |
Why?
| | Sirolimus | 1 | 2012 | 281 | 0.080 |
Why?
| | Bronchiolitis Obliterans | 2 | 2007 | 66 | 0.080 |
Why?
| | Kidney Function Tests | 1 | 2010 | 157 | 0.080 |
Why?
| | Phosphoproteins | 1 | 2012 | 346 | 0.080 |
Why?
| | Length of Stay | 3 | 2006 | 1337 | 0.080 |
Why?
| | Nuclear Cap-Binding Protein Complex | 1 | 2009 | 1 | 0.080 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2012 | 428 | 0.070 |
Why?
| | Esophagogastric Junction | 1 | 2009 | 56 | 0.070 |
Why?
| | Antimicrobial Cationic Peptides | 4 | 1997 | 86 | 0.070 |
Why?
| | Repressor Proteins | 1 | 2012 | 437 | 0.070 |
Why?
| | Mesoderm | 1 | 2009 | 150 | 0.070 |
Why?
| | Cell Cycle Proteins | 1 | 2012 | 629 | 0.070 |
Why?
| | Epithelium | 1 | 2009 | 314 | 0.070 |
Why?
| | Phosphorylation | 1 | 2012 | 1733 | 0.070 |
Why?
| | Sympathectomy | 1 | 2007 | 7 | 0.070 |
Why?
| | Hyperhidrosis | 1 | 2007 | 7 | 0.070 |
Why?
| | Angioplasty, Balloon, Coronary | 1 | 2008 | 158 | 0.060 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 2 | 2007 | 923 | 0.060 |
Why?
| | Thoracoscopy | 1 | 2007 | 62 | 0.060 |
Why?
| | Thoracic Surgery, Video-Assisted | 1 | 2007 | 48 | 0.060 |
Why?
| | Thoracotomy | 1 | 2007 | 83 | 0.060 |
Why?
| | Transplantation, Homologous | 2 | 2006 | 415 | 0.060 |
Why?
| | Diaphragm | 1 | 2006 | 49 | 0.060 |
Why?
| | Case-Control Studies | 2 | 2012 | 3608 | 0.060 |
Why?
| | Postoperative Period | 1 | 2007 | 354 | 0.060 |
Why?
| | Peritonitis | 2 | 1997 | 84 | 0.060 |
Why?
| | Stomach | 1 | 2006 | 109 | 0.060 |
Why?
| | Forced Expiratory Volume | 1 | 2007 | 449 | 0.060 |
Why?
| | Aged | 6 | 2008 | 25947 | 0.060 |
Why?
| | Tissue Preservation | 1 | 2005 | 12 | 0.060 |
Why?
| | Citrates | 1 | 2005 | 41 | 0.060 |
Why?
| | Analysis of Variance | 2 | 2006 | 1311 | 0.060 |
Why?
| | Risk Factors | 3 | 2005 | 10792 | 0.060 |
Why?
| | Gram-Negative Bacterial Infections | 2 | 1996 | 51 | 0.060 |
Why?
| | Drug Delivery Systems | 1 | 2009 | 381 | 0.060 |
Why?
| | Pneumonectomy | 1 | 2007 | 169 | 0.060 |
Why?
| | Escherichia coli | 4 | 1997 | 855 | 0.060 |
Why?
| | Kaplan-Meier Estimate | 1 | 2008 | 966 | 0.060 |
Why?
| | Blotting, Southern | 1 | 2004 | 85 | 0.050 |
Why?
| | Proto-Oncogenes | 1 | 2004 | 29 | 0.050 |
Why?
| | Polymorphism, Restriction Fragment Length | 1 | 2004 | 64 | 0.050 |
Why?
| | Chromosomes, Human, Pair 17 | 1 | 2004 | 55 | 0.050 |
Why?
| | Cell Proliferation | 1 | 2012 | 2499 | 0.050 |
Why?
| | Computer Systems | 1 | 2004 | 56 | 0.050 |
Why?
| | Zebrafish | 1 | 2009 | 528 | 0.050 |
Why?
| | Trastuzumab | 1 | 2004 | 118 | 0.050 |
Why?
| | Cell Line | 4 | 1997 | 2882 | 0.050 |
Why?
| | Antibodies, Monoclonal | 2 | 2004 | 1524 | 0.050 |
Why?
| | Logistic Models | 2 | 2008 | 2119 | 0.050 |
Why?
| | Phenotype | 1 | 2012 | 3164 | 0.050 |
Why?
| | Multigene Family | 1 | 2004 | 204 | 0.050 |
Why?
| | Confidence Intervals | 1 | 2003 | 333 | 0.050 |
Why?
| | Echocardiography, Doppler | 1 | 2003 | 115 | 0.050 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2004 | 758 | 0.040 |
Why?
| | Predictive Value of Tests | 1 | 2007 | 2118 | 0.040 |
Why?
| | Polymerase Chain Reaction | 1 | 2004 | 1054 | 0.040 |
Why?
| | Societies, Medical | 1 | 2006 | 887 | 0.040 |
Why?
| | Hospitals, University | 1 | 2002 | 176 | 0.040 |
Why?
| | Comorbidity | 2 | 2008 | 1660 | 0.040 |
Why?
| | Minnesota | 1 | 2002 | 169 | 0.040 |
Why?
| | Transfection | 2 | 2009 | 940 | 0.040 |
Why?
| | Combined Modality Therapy | 1 | 2003 | 1268 | 0.040 |
Why?
| | Oxygen | 1 | 2006 | 995 | 0.040 |
Why?
| | Intraoperative Complications | 1 | 2001 | 156 | 0.040 |
Why?
| | Sepsis | 2 | 1997 | 641 | 0.040 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2004 | 988 | 0.030 |
Why?
| | Heart Diseases | 1 | 2002 | 350 | 0.030 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 1 | 2007 | 1182 | 0.030 |
Why?
| | Prospective Studies | 1 | 2010 | 7997 | 0.030 |
Why?
| | Patient Selection | 1 | 2002 | 719 | 0.030 |
Why?
| | Gene Expression Profiling | 1 | 2004 | 1786 | 0.030 |
Why?
| | Antibodies, Anti-Idiotypic | 1 | 1997 | 51 | 0.030 |
Why?
| | Candidiasis | 1 | 1997 | 64 | 0.030 |
Why?
| | Candida albicans | 1 | 1997 | 61 | 0.030 |
Why?
| | Lipid A | 1 | 1997 | 28 | 0.030 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2009 | 983 | 0.030 |
Why?
| | Pseudomonas aeruginosa | 2 | 1997 | 356 | 0.030 |
Why?
| | Mice | 8 | 1997 | 18365 | 0.030 |
Why?
| | Antibodies, Bacterial | 1 | 1997 | 148 | 0.030 |
Why?
| | Serratia marcescens | 1 | 1996 | 18 | 0.030 |
Why?
| | Klebsiella pneumoniae | 1 | 1996 | 47 | 0.030 |
Why?
| | Adolescent | 2 | 2006 | 22453 | 0.030 |
Why?
| | Receptors, Tumor Necrosis Factor | 1 | 1996 | 163 | 0.030 |
Why?
| | Receptors, Interleukin-1 | 1 | 1996 | 214 | 0.030 |
Why?
| | Child | 2 | 2006 | 22657 | 0.030 |
Why?
| | Acute-Phase Proteins | 1 | 1995 | 67 | 0.030 |
Why?
| | Macrophage Activation | 1 | 1996 | 193 | 0.030 |
Why?
| | Animals | 9 | 2009 | 38109 | 0.030 |
Why?
| | Lung Neoplasms | 1 | 2007 | 2642 | 0.030 |
Why?
| | Antigens, CD | 1 | 1996 | 555 | 0.020 |
Why?
| | Surgical Wound Infection | 1 | 1996 | 316 | 0.020 |
Why?
| | Molecular Sequence Data | 3 | 2009 | 2931 | 0.020 |
Why?
| | Membrane Glycoproteins | 1 | 1995 | 496 | 0.020 |
Why?
| | Carrier Proteins | 1 | 1995 | 737 | 0.020 |
Why?
| | Interleukin-6 | 1 | 1995 | 780 | 0.020 |
Why?
| | Cytokines | 2 | 1996 | 2065 | 0.020 |
Why?
| | Phosphoric Acids | 1 | 2009 | 17 | 0.020 |
Why?
| | Eukaryotic Initiation Factor-4E | 1 | 2009 | 32 | 0.020 |
Why?
| | Inhibitory Concentration 50 | 1 | 2009 | 91 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2001 | 8279 | 0.020 |
Why?
| | Amides | 1 | 2009 | 101 | 0.020 |
Why?
| | Embryo, Nonmammalian | 1 | 2009 | 173 | 0.020 |
Why?
| | Gene Knockdown Techniques | 1 | 2009 | 336 | 0.020 |
Why?
| | Tumor Cells, Cultured | 1 | 2009 | 919 | 0.020 |
Why?
| | Electrocoagulation | 1 | 2007 | 36 | 0.020 |
Why?
| | Chi-Square Distribution | 1 | 2008 | 529 | 0.020 |
Why?
| | Cell Cycle | 1 | 2009 | 597 | 0.010 |
Why?
| | Cell Survival | 1 | 2009 | 1098 | 0.010 |
Why?
| | Organ Preservation Solutions | 1 | 2005 | 47 | 0.010 |
Why?
| | Pulmonary Gas Exchange | 1 | 2005 | 119 | 0.010 |
Why?
| | Base Sequence | 1 | 2009 | 2191 | 0.010 |
Why?
| | Reoperation | 1 | 2007 | 631 | 0.010 |
Why?
| | Cardiopulmonary Bypass | 1 | 2006 | 221 | 0.010 |
Why?
| | Mice, Inbred BALB C | 2 | 1997 | 1253 | 0.010 |
Why?
| | Amino Acid Sequence | 2 | 1997 | 2157 | 0.010 |
Why?
| | Intensive Care Units | 1 | 2005 | 916 | 0.010 |
Why?
| | Registries | 1 | 2007 | 2385 | 0.010 |
Why?
| | Epitope Mapping | 1 | 1997 | 61 | 0.010 |
Why?
| | Mucins | 1 | 1997 | 76 | 0.010 |
Why?
| | Endotoxemia | 1 | 1997 | 87 | 0.010 |
Why?
| | Receptors, Tumor Necrosis Factor, Type I | 1 | 1996 | 81 | 0.010 |
Why?
| | Bacterial Toxins | 1 | 1996 | 110 | 0.010 |
Why?
| | Mice, Inbred Strains | 1 | 1996 | 397 | 0.010 |
Why?
| | Adjuvants, Immunologic | 1 | 1997 | 245 | 0.010 |
Why?
| | Hemoglobins | 1 | 1997 | 384 | 0.010 |
Why?
| | Disease Susceptibility | 1 | 1996 | 348 | 0.010 |
Why?
| | Bacteremia | 1 | 1996 | 221 | 0.010 |
Why?
| | Binding Sites | 1 | 1997 | 1331 | 0.010 |
Why?
| | Neoplasms | 1 | 2009 | 2884 | 0.010 |
Why?
| | Lymphocytes | 1 | 1995 | 382 | 0.010 |
Why?
| | Mice, Transgenic | 1 | 1996 | 2185 | 0.010 |
Why?
| | United States | 1 | 2008 | 15988 | 0.000 |
Why?
| | Mice, Knockout | 1 | 1996 | 3125 | 0.000 |
Why?
| | Bacteria | 1 | 1995 | 889 | 0.000 |
Why?
| | Genetic Predisposition to Disease | 1 | 1996 | 2365 | 0.000 |
Why?
| | Cells, Cultured | 1 | 1995 | 4155 | 0.000 |
Why?
| | Mice, Inbred C57BL | 1 | 1996 | 5997 | 0.000 |
Why?
| | Signal Transduction | 1 | 1996 | 5233 | 0.000 |
Why?
|
|
Dahlberg's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|